REDOX LIMITED (RDX)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

RDX

RDX - REDOX LIMITED

Year End: June
GICS Industry Group : Capital Goods
Debt/EBITDA: 0.41
Index: ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$2.65

22 Aug
2025

0.050

OPEN

$2.66

1.92%

HIGH

$2.73

3,578,307

LOW

$2.56

TARGET
$3.353 26.5% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AIM . ANN . ASB . CUP . DGL . IMB . KPG . SRV .
FNARENA'S MARKET CONSENSUS FORECASTS
RDX: 1
Title FY24
Actual
FY25
Actual
FY26
Forecast
FY27
Forecast
EPS (cps) xxx 14.7 16.5 xxx
DPS (cps) xxx 12.5 11.6 xxx
EPS Growth xxx - 14.7% 12.6% xxx
DPS Growth xxx 0.0% - 6.9% xxx
PE Ratio xxx N/A 15.6 xxx
Dividend Yield xxx N/A 4.5% xxx
Div Pay Ratio(%) xxx 85.1% 70.4% xxx

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

4.84

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 01/03 - ex-div 6c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx14.7
DPS All xxxxxxxxxxxxxxx12.5
Sales/Revenue xxxxxxxxxxxxxxx1,243.8 M
Book Value Per Share xxxxxxxxxxxxxxx103.7
Net Operating Cash Flow xxxxxxxxxxxxxxx47.8 M
Net Profit Margin xxxxxxxxxxxxxxx6.20 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx14.34 %
Return on Invested Capital xxxxxxxxxxxxxxx13.65 %
Return on Assets xxxxxxxxxxxxxxx10.75 %
Return on Equity xxxxxxxxxxxxxxx14.34 %
Return on Total Capital xxxxxxxxxxxxxxx19.12 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-22.9 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx23 M
Long Term Debt xxxxxxxxxxxxxxx27 M
Total Debt xxxxxxxxxxxxxxx50 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx124 M
Price To Book Value xxxxxxxxxxxxxxx2.08

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx5.1 M
Capex % of Sales xxxxxxxxxxxxxxx0.41 %
Cost of Goods Sold xxxxxxxxxxxxxxx975 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx157 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.8

No. Of Recommendations

3
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

22/08/2025

1

Overweight

$3.50

32.08%

Redox’s FY25 result came in better than Morgan Stanley's recently revised expectations and broadly in line with post-February resets.

A straightforward result highlighted a resilient growth profile, competitive positioning, and optionality from acquisitions, suggest the analysts.

Revenue was $1,244m, up 9% year-on-year, with A&NZ growing 10% and US revenue down -3.6% due to second-half tariff disruptions, explain the analysts.

Gross margin of 21.6% was flat half-on-half, providing confidence to the broker the product mix has normalised.

Operating costs were well managed, in the broker's view. Profit of $80.1m came in slightly ahead of the $75.3m consensus. Free cash flow conversion improved to 41% from 20% in the first half, while net cash ended at $124m.

The broker highlights the absence of formal guidance but sees resilience in the result and a focus on strategic initiatives including M&A.

Overweight rating retained. Target price rises to $3.50 from $3.40. Industry view: In-Line.

FORECAST
Morgan Stanley forecasts a full year FY26 dividend of 10.40 cents and EPS of 15.90 cents.
Morgan Stanley forecasts a full year FY27 dividend of 11.40 cents and EPS of 17.60 cents.

Ord Minnett

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

RDX STOCK CHART